Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3K Hold
234
﹤0.01% 216
2026
Q1
$12.9K Hold
234
﹤0.01% 201
2025
Q4
$11.5K Hold
234
﹤0.01% 221
2025
Q3
$10.1K Hold
234
﹤0.01% 228
2025
Q2
$8.99K Hold
234
﹤0.01% 220
2025
Q1
$9.06K Hold
234
﹤0.01% 203
2024
Q4
$7.91K Hold
234
﹤0.01% 215
2024
Q3
$9.57K Hold
234
﹤0.01% 203
2024
Q2
$9.01K Hold
234
﹤0.01% 209
2024
Q1
$10K Hold
234
0.01% 208
2023
Q4
$8.67K Hold
234
﹤0.01% 229
2023
Q3
$8.48K Hold
234
0.01% 179
2023
Q2
$8.34K Buy
+234
New +$8.39K 0.01% 193

Other funds holding GSK

CGC Financial Services's GSK Position: Q2 2026 in Review

CGC Financial Services held its GSK (GSK) position steady in Q2 2026 at 234 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #216.

CGC Financial Services first reported a position in GSK in Q2 2023 and has held it in 13 quarters since. The position peaked at $12.9K in Q1 2026. 161 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • CGC Financial Services held 234 shares of GSK worth $12.3K as of Q2 2026.
  • CGC Financial Services left its GSK share count unchanged in Q2 2026.
  • GSK made up ﹤0.01% of CGC Financial Services's portfolio in Q2 2026, its #216 holding.
  • CGC Financial Services first reported a position in GSK in Q2 2023 and has held it in 13 quarters since.
  • CGC Financial Services's GSK position peaked at $12.9K in Q1 2026.
  • 161 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on CGC Financial Services's 13F filing for Q2 2026, filed 13 Jul 2026.